Elon Musk's Ketamine Use Ruled Inadmissible in OpenAI Fraud Trial
Key Takeaways
- ▸Court ruled Musk's ketamine use cannot be used as evidence in OpenAI fraud trial
- ▸Decision restricts scope of personal information admissible in the case
- ▸Ruling reflects legal standards on relevance and admissibility of evidence
Source:
Summary
A court has ruled that evidence regarding Elon Musk's ketamine use is inadmissible in an ongoing fraud trial involving OpenAI. The decision limits the scope of personal information that can be introduced against Musk in the legal proceedings. This ruling comes as part of broader litigation surrounding OpenAI's governance and founding history. The case continues to unfold as it examines allegations related to the AI company's organizational structure and decision-making.
- OpenAI litigation remains active regarding governance and corporate structure
